Literature DB >> 29094103

Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model for Multidisciplinary Oncology Care in Low- and Middle-Income Settings.

Surbhi Grover1, Sebathu Philip Chiyapo1, Priya Puri1, Mohan Narasimhamurthy1, Babe Eunice Gaolebale1, Neo Tapela1, Doreen Ramogola-Masire1, Mukendi K A Kayembe1, Thabo Moloi1, Ponatshego Andrew Gaolebale1.   

Abstract

PURPOSE: Cervical cancer is a major cause of mortality in low- and middle-income countries (LMICs) and the most common cancer diagnosed in women in Botswana. Most women present with locally advanced disease, requiring chemotherapy and radiation. Care co-ordination requires input from a multidisciplinary team (MDT) to deliver appropriate, timely treatment. However, there are limited published examples of MDT implementation in LMICs.
METHODS: In May 2015, a weekly MDT clinic for gynecologic cancer care was initiated at Botswana's national referral facility. The MDT clinic served as a forum for discussion and coordination of patients with gynecologic cancer and consisted of a gynecologist, pathologist, medical oncologist, radiation oncologist, palliative care specialist, and nurse coordinator.
RESULTS: Between May 2015 and December 2015, 135 patients were seen in the MDT clinic. The mean age of the patients was 49 years. Most (60%) of the patients were HIV positive. The most common diagnosis was cervical cancer (60%), followed by high-grade cervical intraepithelial neoplastic lesions (12%) and vulvar cancer (11%). Only data up to September 2015 were assessed for treatment delays. It was found that only 38% of patients needed more than one visit for care coordination before treatment initiation. Among patients with cervical cancer, the median delay from date of biopsy to start of radiation treatment was 39 days (interquartile range, 34 to 57 days) for patients treated after MDT initiation, compared with 108 days (interquartile range, 71 to 147 days) for patients treated before MDT initiation (P < .001).
CONCLUSION: Implementation of MDT clinics in LMICs is feasible and can help reduce delays in treatment initiation, as demonstrated by a gynecologic MDT clinic in Botswana. Streamlining care through MDT clinics can enhance care coordination and improve clinical outcomes. This model can apply to cancer care in other LMICs.

Entities:  

Year:  2017        PMID: 29094103      PMCID: PMC5646885          DOI: 10.1200/JGO.2016.006353

Source DB:  PubMed          Journal:  J Glob Oncol        ISSN: 2378-9506


INTRODUCTION

Cervical cancer is the fourth most common cancer affecting women worldwide, with an estimated 528,000 new cases and 266,000 deaths annually.[1] Approximately 85% of these new cases and 87% of deaths occur in low- and middle-income countries (LMICs).[1] Because of limited screening programs and high HIV prevalence, cervical cancer is the leading cause of cancer death in Botswana.[2] More than 75% of patients with cervical cancer in Botswana have locally advanced disease.[3] In Botswana, current treatment includes radiotherapy and cisplatin-based chemotherapy. Radiotherapy, however, is not available in the public sector; hence, patients are referred to the private sector for radiation. On the basis of our pilot data, the median time from diagnosis to treatment is 108 days.[3] To decrease cervical cancer morbidity and mortality, it is imperative to identify and address factors contributing to delays. Cancer management requires action from a range of expert providers over a prolonged time.[4] Difficulties in communication and coordination among these various providers can cause cancer care to become fragmented, ultimately contributing to treatment delays and worse outcomes,[5,6] which are a potential cause of delay in cervical cancer care in Botswana. Studies in developed countries in which surgeons, pathologists, oncologists, radiologists, social workers or psychologists, and nurses are involved in discussing each case[7] suggest that multidisciplinary teams (MDTs) can decrease time to diagnosis, time to treatment, and duplication of investigations, as well as improve accuracy of diagnosis.[8] Thus, the establishment of an MDT is warranted. Actionable knowledge about scaling MDTs into LMICs remains sparse. Results from an international survey showed that breast cancer MDT clinics across the world used different models and lacked standard guidelines.[9] In several developing countries, cancer centers do not have formal MDTs.[10] Another survey in Arab countries revealed that only 49% of respondents reported having MDTs.[11] This could be because establishing MDT clinics in LMICs is difficult because of competing health-care demands, limited health-care personnel, and poor infrastructure.[12,13] Although there are established oncology MDT clinics in LMICs in Africa, such as in Uganda and Egypt, there have been no published studies on the direct benefits of these MDT clinics.[14,15] The purpose of this paper is to describe the implementation and early outcomes of a gynecologic MDT clinic in Botswana, which, to our knowledge, is the first gynecologic MDT clinic in an LMIC. We also describe the impact of the MDT clinic on reducing treatment delay.

METHODS

Organization Before Weekly Meeting

Through a collaborative effort across providers, we established a weekly gynecologic MDT clinic at Botswana’s national referral facility in Gaborone. A nurse coordinator was assigned to manage patient flow. All new referrals with basic information, including stage, date of biopsy, results of biopsy specimen assessment, and HIV status, were sent to the nurse coordinator, who then procures patient records and ensures that biopsy results are available. All patients to be discussed were contacted by the coordinator the day before the clinic meeting.

Workflow During Weekly Meeting

At the beginning of each clinic meeting, a team composed of a radiation oncologist, clinical oncologist, gynecologist, pathologist, nurse coordinator, and palliative care specialist discuss all patients referred to the MDT clinic. Together, an oncologist and gynecologist examine patients and determine an appropriate care plan. If the patient requires radiation, paperwork to document sponsorship of treatment by the government of Botswana is completed and submitted to the referral office. Investigations for staging or treatment planning are ordered if they have not been done previously. If patients are HIV positive or untested, they are referred to an HIV clinic for antiretroviral treatment evaluation or retesting for HIV. Patients are then counseled on the treatment plan by an oncologist, gynecologist, and palliative care doctor, and given a follow-up date in 2 weeks to make sure all the investigations are completed and all submitted documents are processed. We evaluated the patient characteristics and radiation treatment delays in patients seen in this clinic. The Wilcoxon rank-sum test was used to compare the delay in treatment before and after MDT clinic initiation. Only data up to September 2015 were assessed for treatment delays, because the radiation department in Botswana closed in September 2015 for an upgrade and patients were referred to South Africa.

RESULTS

A gynecologic MDT clinic was initiated at Princess Marina Hospital in May 2015. Between May and December 2015, 135 patients were seen in this clinic, with an average of 28 patients per month. Most patients (n = 82; 60%) were HIV positive, 31% (n = 42) were HIV negative, and the HIV status of 11 patients was unknown. The most common diagnosis of patients who came to the MDT clinic was cervical cancer (60%), followed by high-grade preinvasion, or cervical intraepithelial neoplasia 3, lesions (12%) and vulvar cancer (11%). Forty-two percent of patients (n = 57) had locally advanced cancer and needed chemoradiation. Further details of patients seen in the clinic are listed in Table 1. Sixty-two percent of patients (n = 83) needed only one visit for care coordination. Treatment delays were evaluated for radiation treatment as well as surgery. The median delay from date of biopsy to start of radiation treatment was 39 days (interquartile range [IQR], 34 to 57 days) after MDT initiation, compared with 108 days (IQR, 71 to 147 days; P < .001) before MDT initiation. The median delay from clinic visit to the start of radiation treatment was 24 days (IQR, 19 to 31 days) and median delay from clinic visit to surgery was 31 days (IQR, 13 to 43 days) after MDT initiation (Table 2).
Table 1

Patient, Clinical, and Treatment Characteristics of Patients Seen in a Multidisciplinary Gynecologic Oncology Clinic in Botswana, May 2015 Through December 2015

Table 2

Clinic Visits for Gynecologic Oncology Multidisciplinary Clinic in Botswana, May Through December 2015

Patient, Clinical, and Treatment Characteristics of Patients Seen in a Multidisciplinary Gynecologic Oncology Clinic in Botswana, May 2015 Through December 2015 Clinic Visits for Gynecologic Oncology Multidisciplinary Clinic in Botswana, May Through December 2015

DISCUSSION

The complexity of cancer care makes it vulnerable to delay and suboptimal outcomes. By enhancing communication and streamlining care, MDTs are important in reducing treatment delays and improving patient outcomes. The results from the establishment of a gynecologic MDT clinic in Botswana are promising. The time from diagnosis to the start of radiation treatment was reduced by greater than 50% following initiation of the MDT clinic. Furthermore, only 38.5% of patients needed more than one clinic visit, suggesting that even one visit to the MDT clinic was sufficient to facilitate patient navigation through the system. Similar MDT models are also being piloted for head and neck, palliative care, and breast cancer in Botswana. A follow-up clinic is being piloted where all patients treated with gynecologic cancer are seen after treatment or followed up until signs of toxicities or recurrence appear. All the patients seen in the MDT clinic will be linked to the follow-up clinic and will receive regular reminders for a visit or a telephone call for follow-up. In summary, establishment of an MDT clinic in LMIC settings is feasible. It can help with care coordination and reducing delays, and can be used more broadly as a model of cancer care for all cancers in Botswana and other LMICs.
  13 in total

Review 1.  Examining the potential relationship between multidisciplinary cancer care and patient survival: an international literature review.

Authors:  Nicole J Look Hong; Frances C Wright; Anna R Gagliardi; Lawrence F Paszat
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

2.  Multidisciplinary care in the oncology setting: historical perspective and data from lung and gynecology multidisciplinary clinics.

Authors:  Laura Elise Horvath; Edgardo Yordan; Deepak Malhotra; Ileana Leyva; Katy Bortel; Denise Schalk; Patricia Mellinger; Marianne Huml; Christy Kesslering; Jeffrey Huml
Journal:  J Oncol Pract       Date:  2010-11       Impact factor: 3.840

3.  Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries.

Authors:  K S Saini; C Taylor; A-J Ramirez; C Palmieri; U Gunnarsson; H J Schmoll; S M Dolci; C Ghenne; O Metzger-Filho; M Skrzypski; M Paesmans; L Ameye; M J Piccart-Gebhart; E de Azambuja
Journal:  Ann Oncol       Date:  2011-08-04       Impact factor: 32.976

4.  Problem solving for breast health care delivery in low and middle resource countries (LMCs): consensus statement from the Breast Health Global Initiative.

Authors:  Joe B Harford; Isabel V Otero; Benjamin O Anderson; Eduardo Cazap; William J Gradishar; Julie R Gralow; Gabrielle M Kane; Laurens M Niëns; Peggy L Porter; Anne V Reeler; Paula T Rieger; Lillie D Shockney; Lawrence N Shulman; Tanya Soldak; David B Thomas; Beti Thompson; David P Winchester; Sten G Zelle; Rajendra A Badwe
Journal:  Breast       Date:  2011-03-04       Impact factor: 4.380

5.  Survey of utilization of multidisciplinary management tumor boards in Arab countries.

Authors:  Nagi S El Saghir; Nadine El-Asmar; Carla Hajj; Toufic Eid; Sami Khatib; Adda Bounedjar; Dahish Ajarim; Ali Shamseddine; Fady Geara; Abdelrahman Jazieh; Hamdy A Azim; Yasser Abdelkader; Joseph Kattan; Omalkhair Abulkhair
Journal:  Breast       Date:  2011-02-12       Impact factor: 4.380

Review 6.  Multidisciplinary teams in cancer care: are they effective in the UK?

Authors:  Anne Fleissig; Valerie Jenkins; Susan Catt; Lesley Fallowfield
Journal:  Lancet Oncol       Date:  2006-11       Impact factor: 41.316

7.  Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007.

Authors:  Benjamin O Anderson; Cheng-Har Yip; Robert A Smith; Roman Shyyan; Stephen F Sener; Alexandru Eniu; Robert W Carlson; Edward Azavedo; Joe Harford
Journal:  Cancer       Date:  2008-10-15       Impact factor: 6.860

8.  Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.

Authors:  Eileen M Kesson; Gwen M Allardice; W David George; Harry J G Burns; David S Morrison
Journal:  BMJ       Date:  2012-04-26

9.  Cancer of the breast: 5-year survival in a tertiary hospital in Uganda.

Authors:  A Gakwaya; J B Kigula-Mugambe; A Kavuma; A Luwaga; J Fualal; J Jombwe; M Galukande; D Kanyike
Journal:  Br J Cancer       Date:  2008-06-24       Impact factor: 7.640

Review 10.  Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs.

Authors:  Surbhi Grover; Mmakgomo Raesima; Memory Bvochora-Nsingo; Sebathu P Chiyapo; Dawn Balang; Neo Tapela; Onyinye Balogun; Mukendi K A Kayembe; Anthony H Russell; Barati Monare; Senate Tanyala; Jailakshmi Bhat; Kealeboga Thipe; Metlha Nchunga; Susan Mayisela; Balladiah Kizito; Ari Ho-Foster; Babe Eunice Gaolebale; Ponatshego A Gaolebale; Jason A Efstathiou; Scott Dryden-Peterson; Nicola Zetola; Stephen M Hahn; Erle S Robertson; Lilie L Lin; Chelsea Morroni; Doreen Ramogola-Masire
Journal:  Front Oncol       Date:  2015-11-03       Impact factor: 6.244

View more
  15 in total

Review 1.  Enhancing Career Paths for Tomorrow's Radiation Oncologists.

Authors:  Neha Vapiwala; Charles R Thomas; Surbhi Grover; Mei Ling Yap; Timur Mitin; Lawrence N Shulman; Mary K Gospodarowicz; John Longo; Daniel G Petereit; Ronald D Ennis; James A Hayman; Danielle Rodin; Jeffrey C Buchsbaum; Bhadrasain Vikram; May Abdel-Wahab; Alan H Epstein; Paul Okunieff; Joel Goldwein; Patrick Kupelian; Joanne B Weidhaas; Margaret A Tucker; John D Boice; Clifton David Fuller; Reid F Thompson; Andrew D Trister; Silvia C Formenti; Mary-Helen Barcellos-Hoff; Joshua Jones; Kavita V Dharmarajan; Anthony L Zietman; C Norman Coleman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-05-22       Impact factor: 7.038

2.  Survival Impact and Cost-Effectiveness of a Multidisciplinary Tumor Board for Breast Cancer in Mozambique, Sub-Saharan Africa.

Authors:  Mariana Brandão; Assucena Guisseve; Carla Carrilho; Nuno Lunet; Genoveva Bata; João Firmino-Machado; Matos Alberto; Josefo Ferro; Carlos Garcia; Clésio Zaqueu; Astrilde Jamisse; Cesaltina Lorenzoni; Martine Piccart-Gebhart; Dina Leitão; Jotamo Come; Otília Soares; Alberto Gudo-Morais; Fernando Schmitt; Satish Tulsidás
Journal:  Oncologist       Date:  2021-01-06

3.  Vulvar cancer in Botswana in women with and without HIV infection: patterns of treatment and survival outcomes.

Authors:  Emily MacDuffie; Sruthi Sakamuri; Rebecca Luckett; Qiao Wang; Memory Bvochara-Nsingo; Barati Monare; Lisa Bazzett-Matabele; Thabo Moloi; Tlotlo Ralefala; Doreen Ramogola-Masire; Sanghyuk S Shin; Nicola M Zetola; Surbhi Grover
Journal:  Int J Gynecol Cancer       Date:  2021-09-07       Impact factor: 3.437

4.  Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018.

Authors:  Shekinah Nefreteri Cluff Elmore; Melinda Mushonga; Hari Subramaniam Iyer; Caroline Kanda; Shirley Chibonda; Fallon Chipidza; Rudo Makunike Mutasa; David Muchuweti; Edwin G Muguti; Aspect Maunganidze; Ntokozo Ndlovu; Jennifer Ruth Bellon; Anna Mary Nyakabau
Journal:  Cancer Med       Date:  2021-05-10       Impact factor: 4.452

5.  Timelines to Cervical Cancer Diagnosis and Treatment at a Tertiary Hospital in Botswana.

Authors:  Mercy-Nkuba Nassali; Tadele Melese; Jamieson Modimowame; Badani Moreri-Ntshabele
Journal:  Int J Womens Health       Date:  2021-04-23

6.  Patient Factors Associated With Delays in Obtaining Cancer Care in Botswana.

Authors:  Rohini K Bhatia; Sarah Rayne; William Rate; Lame Bakwenabatsile; Barati Monare; Chidinma Anakwenze; Preet Dhillon; Mohan Narasimhamurthy; Scott Dryden-Peterson; Surbhi Grover
Journal:  J Glob Oncol       Date:  2018-08

7.  Dermatology-Driven Quality Improvement Interventions to Decrease Diagnostic Delays for Kaposi Sarcoma in Botswana.

Authors:  Victoria L Williams; Mohan Narasimhamurthy; Olaf Rodriguez; Karen Mosojane; Thapelo Bale; Koorileng Kesalopa; Mukendi A Kayembe; Surbhi Grover
Journal:  J Glob Oncol       Date:  2019-11

8.  Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.

Authors:  Surbhi Grover; Matthew S Ning; Michelle Bale; Katie E Lichter; Sidrah Shah; Memory Bvochora-Nsingo; Sebathu Chiyapo; Dawn Balang; Gwendolyn J McGinnis; Tlotlo Ralefala; Thabo Moloi; Rebecca Luckett; Doreen Ramogola-Masire; Erle S Robertson; Nicola M Zetola
Journal:  Int J Gynecol Cancer       Date:  2021-07-26       Impact factor: 3.437

9.  Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.

Authors:  Anne Marie McCarthy; Surbhi Grover; Tara M Friebel-Klingner; Rebecca Luckett; Lisa Bazzett-Matabele; Tlotlo B Ralefala; Barati Monare; Mercy Nkuba Nassali; Doreen Ramogola-Masire; Memory Bvochora; Nandita Mitra; Douglas Wiebe; Timothy R Rebbeck
Journal:  BMC Womens Health       Date:  2021-07-06       Impact factor: 2.809

10.  Pilot of an International Collaboration to Build Capacity to Provide Gynecologic Oncology Surgery in Botswana.

Authors:  Rebecca Luckett; Kitenge Kalenga; Fong Liu; Katharine Esselen; Chris Awtrey; Mompati Mmalane; Thabo Moloi; Hope Ricciotti; Surbhi Grover
Journal:  Int J Gynecol Cancer       Date:  2018-11       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.